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Abstract: Laboratory data is a treasure chest for person-
alized medicine: it is – in general – electronically avail-
able, highly structured, quality controlled and indicative 
for many diseases. However, it is also a box with (prob-
ably more than) seven locks: laboratories use their own 
internal coding systems, results are reported in different 
languages (four official languages plus English with very 
distinct features in Switzerland), report formats are not 
uniform, standard nomenclature (e.g. Logical Observation 
Identifiers Names and Codes [LOINC]) is not routinely used 
and even these coding systems lack important informa-
tion, including data, for example, about the specific “kit” 
used for testing or preanalytical procedures affecting the 
sample quality and result interpretability. Visualization of 
complex laboratory and reporting “-omics” data are addi-
tional challenges. Currently, there is no “passepartout” key 
for all these locks available, and also newer concepts such 
as Fast Health Interoperability Resources (FHIR) might 
not provide enough plasticity to unconditionally render 
laboratory data interoperable. In this short overview, we 
present current approaches in Switzerland with a specific 
focus on the exemplary Bernese implementations.
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Introduction
In Switzerland, laboratory medicine is a rapidly devel-
oping discipline, not only in university hospital settings, 
but also for outpatient care. While in the last few years 
many efforts were focused on laboratory consolida-
tion, process optimization and automatization, the now 
emerging big data science and data interoperability hold 
excellent promise for making efficient use of laboratory 
data generated in the course of clinical practice. Within 
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this digital revolution, laboratory medicine evolves more 
and more from an analytically focused “number delivery 
service” into a medical data generation and interpretation 
science along with all other scientific fields, which are 
now being entrained with the “digital revolution”.
Looking into existing reality, the scientific community 
has seen a plethora of activities in biomedical and clinical 
data science collection, organization and analysis [1]. Also, 
in Switzerland, national initiatives have been launched, 
e.g. the action plan digitalization of the State Secre-
tariat for Education, Research and Innovation (SERI1), 
the National Research Program “big data” of the Swiss 
National Science Foundation (SNF2), and the Swiss Per-
sonalized Health Network initiative of the Swiss Academy 
of Medical Sciences (SAMS3). All these programs and initia-
tives are intended to strengthen Switzerland’s position at 
the forefront of “digital health” – and they are all utterly 
dependent on the interoperability of their data sources.
Within the healthcare ecosystem, laboratory medicine 
was an early adopter of digitalization, starting with elec-
tronic data capture and display in the 1980s, developing 
electronic process management and becoming increas-
ingly paperless (not to mention a few inglorious excep-
tions). Laboratory data – and medical data in general – are 
complex, partly not perfectly structured and semanti-
cally complex. Exchanging such data requires specific 
normative or structural approaches, as failures in health-
related information provision – particularly in laboratory 
and medication data – are a major contributing factor to 
medical errors. The US Joint Commission has introduced 
different patient safety goals, including test result com-
munication guidelines [2]. Similar approaches have been 
introduced by many countries. In Switzerland, patient 
safety is one of the defined goals of the Swiss electronic 
health record law (Bundesgesetz über das elektronische 
Patientendossier [EPDG]) and will be in force by 2020.4
Today, laboratory reports are usually electronically 
available and highly structured. However, there are spe-
cific features that render the exchange of laboratory 
reports non-trivial:
First, laboratory results do not always consist of only 
numbers: there are tests with free text results, especially 
for complex diagnostics with results that would be unin-
formative for the treating physician, or there might be 
graphs (e.g. for cerebrospinal fluid [CSF] diagnostics, the 
so-called “Reiber” diagrams or flow cytometry scatter-
plots) or images (e.g. in hematology). A future challenge 
will be the transmission of “omics” results – including 
genomics, proteomics, metabolomics and future tech-
niques. In these fields, a large amount of data are gen-
erated, and proper modes have to be found to transmit 
the relevant information in a clinically useful way [3], in 
 Switzerland and beyond.
Second, additional information is needed for an ade-
quate clinical interpretation of laboratory results. This 
could be preanalytical information about the patient or 
the sample [4–6], reference ranges for the specific analy-
sis [7], additional information on the test kit or analytical 
instrument [8–10] or any other relevant “hidden” variable 
[11]. For the documentation of preanalytical variables, the 
Standard PREanalytical Code (SPREC) [12] was introduced 
and is currently in use at the BiobankBern.5 It covers 
many relevant items; however, there is always a delay 
between the introduction of state-of-the-art technology 
for optimal sample pretreatment and its resemblance in 
the code reference (e.g. <2 h pre-centrifugation delay). In 
such cases, an unabridged documentation of all preana-
lytical steps – including the ones without a correspond-
ing code – is necessary to be able to back match own data 
later on to an updated code version. The transmission of 
reference ranges together with the analyte concentrations 
is an issue of its own [13]: whereas a reference range on a 
laboratory report might be intended to support the physi-
cian in assessing a test result as “normal” or not, its sug-
gested generation at each laboratory site renders it highly 
dependent on the hospital’s patient cohort and thereby 
per se different between primary and tertiary care pro-
viders. Aside from questioning the concept of the mono-
parametric essence of the current reference ranges itself, 
reporting reference ranges always sets a patient in context 
with a “healthy” control group, which might or might not 
be relevant for the patient’s condition or the scientific 
question of a collaborative project. Much more important 
seems the reporting of the test kit (vendor and version) 
used to generate the result, as different antibody specifi-
cities might yield different results for the same analyte, 
even if the same methodology is used. Actually, there is 
no standardized reporting for this kind of information in 
Switzerland. In contrast to these variables known to be 
important for the interpretation of laboratory test results, 
a large body of not yet correlated nor properly understood 
variables awaits being implemented and considered – the 
1 https://www.sbfi.admin.ch/sbfi/de/home/das-sbfi/digital-
isierung.html.
2 http://www.nfp75.ch/en.
3 http://www.sphn.ch.
4 https://www.admin.ch/opc/de/classified-compilation/20111795/
index.html. 5 http://biobankbern.ch.
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current reporting systems are neither thought nor dimen-
sioned for such requirements: new concepts, e.g. graph-
based semantics could offer solutions to this problem [14].
LOINC in Switzerland
In laboratory medicine, the Logical Observation Identi-
fiers Names and Codes (LOINC) terminology became a 
universal coding system, despite its limitations. LOINC 
was introduced in 1994, and is maintained by a US 
non-profit organization called the Regenstrief Institute.6 
As of today, LOINC is being used in 172 countries across 
the globe and has expanded into additional medical 
fields, such as radiology, pharmacy and others. It is part of 
Clinical Document Architecture as part of the Health Level 
7 standard (HL7 CDA), and thus a resource being able to 
be utilized in other coding systems. In its current version 
2.63, released on December 15, 2017, it includes 86,528 
terms, and many clinical laboratory systems support 
LOINC. Additionally, many, if not all, current electronic 
medical record (EMR) systems are also able to support 
LOINC. Within the USA, LOINC has been widely adopted 
by health information exchanges, reference laboratories, 
healthcare organizations, insurance companies, research 
applications and several national standards. The Depart-
ment of Health and Human Services has adopted LOINC as 
the standard across federal agencies for laboratory result 
names, laboratory test order names and federally required 
patient assessment instruments. LOINC is a source 
vocabulary in the National Library of Medicine’s Unified 
Medical Language System (UMLS) and was adopted by the 
National Cancer Institute’s cancer Biomedical Informat-
ics Grid through a formal review process [15]. Moreover, 
LOINC was adopted as the standard for laboratory orders 
and results as part of the Centers for Medicare and Medic-
aid Services Electronic Health Record (EHR) “Meaningful 
Use” incentive program in the Standards and Certification 
Criteria.
In Switzerland, LOINC is used to render laboratory 
data interoperable, and its country-wide implementation 
is by far more necessary as in Germany: Switzerland has 
four official languages, and four that are more or less reg-
ularly used in medicine throughout the country: German, 
French, Italian and especially in the scientific context 
English. The German “Kalium” is potassium in English and 
French, and potassio in Italian. Although widely in use, 
translation of standard terminology remains challenging, 
particularly regarding acronyms and abbreviations and 
linguistic syntax differences, which might cause specific 
difficulties in a multi-lingual country such as Switzerland. 
For multi-lingual purposes, the Regenstrief organization 
provides a software program called RELMA® (the REgen-
strief LOINC Mapping Assistant) that helps in searching 
the LOINC database and mapping local terminology to 
LOINC terms. Although Switzerland has been amongst 
the first to adopt LOINC back in 2001, led by Jack Bierens 
de Haan at the Centre Suisse de Contrôle de Qualité, the 
current state is that LOINC translations in Swiss-national 
linguistic versions (Swiss French, Swiss German, Swiss 
Italian) lack additional support. Those vocabularies did 
not grow compared to other languages. Within the current 
RELMA® version, all three Swiss linguistic versions of 
LOINC remained at approximately 4900 translated terms, 
whereas the French (Canada) and the Italian (Italy) ver-
sions exceeded 40,000 terms, and the German (Germany) 
version 11,000 terms. As per the current Regenstrief policy, 
only translations of sufficient size (e.g. >10,000 terms) are 
enabled for searching in RELMA®, hence no Swiss linguistic 
version is currently searchable. One specific effort to cope 
with both the multi-linguistic challenges in Switzerland 
and the support of newer concepts, such as genomic infor-
mation, is bundled in a Swiss Personalized Health Network 
(SPHN®) infrastructure development project called LOINC 
for Swiss Laboratories (L4CHLAB).7 The availability of 
large amounts of data on these biological parameters is of 
major importance to research on precision medicine, and 
this particular project, which started in April 2018, aims to 
create the needed semantic interoperability.
LOINC has also been suggested to be mapped with 
the official Swiss reimbursement catalogue (Analysen-
liste AL8); however, the benefit – if restricted on this 
topic – would be at least limited: frequently, the cost 
of an analyte can be estimated by the technique used 
for measurement, and no further specification of the 
analyte would be needed for adequate accounting. At 
present, the codes of the Analysenliste are implemented 
throughout Switzerland, and mapping these with LOINC 
exclusively for reimbursement purposes would have to 
be justified by additional value and, if possible, without 
the restrictions inherent to the LOINC usage. LOINC 
is also suggested as a laboratory result coding system 
within the eHealth Suisse9 environment (exchange format 
6 https://loinc.org.
7 https://www.sphn.ch/en/projects/call-results-2017.html.
8 https://www.bag.admin.ch/bag/de/home/themen/versicherun-
gen/krankenversicherung/krankenversicherung-leistungen-tarife/
Analysenliste.html.
9 https://www.e-health-suisse.ch/fileadmin/user_upload/
Dokumente/2018/D/180507_CDA-CH-LREP_de.pdf.
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eLaboratoryReport  – “Austauschformat eLaborbefund”), 
based on the Sharing Laboratory Reports (XD-LAB) Inte-
gration Profile of the “Integrating the Healthcare Enter-
prise (IHE) initiative” (IHE XD-LAB)10 content profile. 
Although the wide adoption of LOINC has been a success, 
major challenges remain, particularly with the support 
of newer concepts, such as genomics [16], proteomics 
[17], metabolomics [18], and other omics-related ontolo-
gies. Since additional methodologies entered the world 
of healthcare laboratory data management, additional 
ontology-related hurdles also remain to be taken. For 
example, the sequencing of the human genome has led 
to a proliferation of innovative scientific research with 
respect to clinical medicine. This newly created clinical 
knowledge provides challenges for recording, managing 
and using the clinical data that result from that research. 
While many attempts have been demonstrated [16] to 
create terminology models to be utilized for recording 
of clinical genomic data, only LOINC offers meaningful 
content. As the LOINC concept is mainly single-analyte 
based, these techniques generating large datasets of cor-
related data items are not optimally suited to be repre-
sented within LOINC. Additionally, the preprocessing of 
the “omics” data contributes largely to its interpretation; 
therefore, all interactions with the data should likewise be 
stored, if not the “raw” files for later re-processing.
For microbiology testing, the usage of LOINC alone for 
data exchange seems additionally problematic – there are 
innumerous pathogens, sample retrieval sites and second-
ary derived materials (e.g. cultures) that impede a direct 
one-to-one mapping with specific LOINC codes. Amending 
the missing information using the Systematized Nomen-
clature of Human and Veterinary Medicine-Clinical Terms 
(SNOMED CT11) nomenclature seems to be a reasonable 
approach to ensure interoperability for this type of labora-
tory results. Similar is the situation for reporting somatic 
alterations in tumor tissues in pathological reporting. 
Ongoing work examines the applicability of mapping 
LOINC with SNOMED CT to better support laboratory 
information management systems (LIMS), EMR and other 
future implementations [19].
The laboratories are entitled to propose changes to 
LOINC by suggesting additional information that might be 
needed to specify a test, e.g. kit type or versions. Today, the 
Swiss university hospitals are using a highly homogenous 
infrastructure; however, joining data, e.g. with cantonal 
hospitals or outpatient laboratories, is difficult, e.g. tumor 
maker levels are not comparable despite a specific LOINC 
code (e.g. 83084-4 for CA19-9, regardless of vendor). For 
this problem, several approaches exist, such as introduc-
ing extension in FIHR (see below) or a specific mapping of 
LOINC with other reference systems, e.g. via the attribute 
“extended analysis information” in the Austrian Elektron-
ische GesundheitsAkte (ELGA) value set.
With more and more specific and detailed number 
of LOINC codes, that is ever increasing, another problem 
arises: the back-merging. In our daily practice, we fre-
quently see researchers requesting “creatinine”. Depend-
ing on the purpose of their request, we should deliver 
different codes. If it is about measuring creatinine as a 
crude patient safety characteristic, we might report serum 
and whole blood creatinine from point-of-care testing 
(POCT), but if the request is about testing a new estimated 
glomerular filtration rate (eGFR) equation, we probably 
rely on centrally measured isotope dilution mass spectro-
metry (IDMS) calibrated plasma creatinine. Although 
LOINC now offers thematic LOINC groups,12 this only 
partly solves the issues arising with thousands of unique 
LOINC codes in our data repositories: medical expertise 
of a laboratory specialist is anyway needed for valuable 
reporting, and providing clinicians and researchers with 
a non-curated self-service LOINC menu would be at least 
careless.
Fast Health Interoperability 
Resources (FHIR)
An advanced – although still emerging – concept to provide 
and exchange health information data is called Fast Health 
Interoperability Resources (FHIR).13 Although many such 
attempts have been made in the field of medical and labo-
ratory information management, and different standards 
have been implemented (e.g. HL7 v2, HL7 v3, Reference 
Information Model [RIM] and CDA), no such standard is 
able to comply with the ever-increasing complexity of dig-
itization in healthcare. The main goal of FHIR is to ease 
health information interoperability without affecting the 
integrity of information. FHIR has seamless constructs 
for mapping HL7 RIM and other models, thus enabling 
strong ties to HL7’s patterns and best practices without 
the need for in-depth knowledge of the RIM, or HL7 v3. 
However, current health information technology applica-
tions, such as EMR, or LIMS are productive systems and 
cannot be changed rapidly while they are still in daily use. 
10 http://www.ihe.net/Laboratory/.
11 https://www.snomed.org/snomed-ct.
12 https://loinc.org/groups/.
13 https://www.hl7.org/fhir/.
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Additionally, current data standards like HL7 v2 and v3 are 
less familiar, and far more complex as many modern and 
widely used web-based open standards. In order to comply 
with the need for such ultra-fast technology changeability, 
it became obvious to search for a widely supported mecha-
nism to deploy such standards as quickly as possible.
One recent approach to such challenges became 
known as Substitutable Medical Apps and Reusable Tech-
nologies (SMART),14 which incorporates FHIR. As outlined 
before, FHIR was designed to be standard based, open 
source and easy to implement, yet lacking the ability to 
integrate different health information applications. FHIR 
itself does provide definitions for ontologies, data models 
and data exchange methods, but not for accessing data, 
credentials or user interactions. To fill that gap, SMART has 
been defined to provide data profiles, standard authoriza-
tions, authentication technologies, as well as user inter-
face (UI) integration patterns [20]. As of today, no known 
SMART on FHIR implementation has been published for 
LIMS, and the current level of LIMS interoperability, parti-
cularly in Switzerland, remains HL7 v2.x or CDA based. 
For future LIMS implementations, it might be paramount 
to evaluate the level of SMART on FHIR or FHIR readiness. 
Nevertheless, “plasticity” – as predicted by Christian Lovis 
[21] and described as transition of information technology 
to a semantic and temporal centric vision of information 
– will determine whether coding concepts will prevail or 
unlaureled descend in vain.
Laboratory data and clinical data 
warehouses (CDWH)
Recently, academic institutions across the globe have 
established significant efforts in the management of clini-
cal and research data by enabling research data lifecycle 
as a means to support healthcare data acquisition, inges-
tion, curation, preservation, sharing and reuse [21, 22]. 
However, little is known as to what extent the design of 
so-called clinical data warehouses (CDWHs) or research 
data management platforms supports current and future 
requirements from a laboratory medicine point of view, 
particularly for multidimensional datasets. Additionally, 
many of those CDWHs focus on academic or research-
related aspects, whereas their linkage with transactional 
clinical data management for time-critical day-to-day 
practice is missing.
To provide an overview, we describe existing research 
management implementations to draw conclusions for 
both related aspects of laboratory medicine, and particu-
larly for Swiss implementation strategies. The latter will 
impact and likewise be impacted by national Swiss initia-
tives, such as the SPHN.
There are different approaches to organize a CDWH 
architecturally, and no gold standard has been found as of 
today. One very recent design approach seems to be prom-
ising and was considered in building the Inselspital’s own 
CDWH: the requirements described by Nind et al. [23] are 
outlined in the following paragraphs. Additionally, this 
proposal is compared to the preliminary results derived 
from our own research.
1. Horizontal scaling: Most extract, transform, load 
(ETL) frameworks are adjusted for scaling vertically, 
which allows more records per time. The mechanism 
follows an approach to write-once per dataset. Data 
cleansing, data transformation and any optimiza-
tions will be done at hosted data only. However, this 
vertical scaling has limitations when it comes to 
rapid ETL and extraction of heterogeneous datasets, 
particularly mixing complex clinical measurements, 
complex laboratory data and genomic data. The solu-
tion seems to follow both vertical as well as horizon-
tal scaling capabilities, especially in our case with 
several unconnected laboratory information systems 
(LISs), e.g. clinical chemistry and microbiology.
2. Data cleaning and curation tools: The current genera-
tions of research data platforms and CDWHs depend 
on the quality of pre-curated data and the reliability of 
ingested datasets. Additionally, those setups neither 
cope with retrospective rewriting nor with changing 
definitions and reference values, which is happening 
frequently, particularly regarding laboratory para-
meters. To avoid constant manual data clean-up and 
poor data quality, such cleansing and restructuring 
pipeline must be built into future research platforms 
and CDWHs. While currently the datasets from the 
laboratory exceed other source systems in data qual-
ity, new, patient-centered approaches, such as glu-
cose self-monitoring or closed-loop devices, require a 
considerable amount of data curation (or at least the 
tagging of the source systems to enable both compre-
hensive and high-quality data queries).
3. Multifaceted extraction conversions: Current design 
approaches seem to lack the ability to facilitate multi-
dimensional and frequent transformations. The latter 
is particularly important when it comes to optimizing 
and adapting datasets to feed into machine learning 
environments. At the Inselspital, we currently use 14 https://smarthealthit.org.
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Markdown-based combined R and Structured Query 
Language (SQL) scripts to provide maximum flexibil-
ity together with thorough documentation.
4. Data lifecycle management: The current design fol-
lows a single data management resource approach, 
thus allowing access to many researchers. However, 
this conflicts with the approach to optimize cleansing 
and standardization of data. Hence, we implemented 
different data delivery options, from single file trans-
fer of raw query outputs to highly customized reports 
including computations and graphics to meet the dif-
ferent requirements of researchers and clinicians.
5. Governance implementation: One of the high-level 
tasks in implementing a CDWH is the proper represen-
tation of institutional and study-related governance 
(cf. SPHN project “Development of a governance and 
quality management system for exchange of patient 
related data for research purposes.”7). Without doubt, 
the different interests of data providers and/or data 
users are a challenge, which in our case is tackled by 
rigorous adherence to the permissions given in ethi-
cal waivers and an institutional board that assesses 
each request on the basis of intention of and fitness for 
purpose (as much as necessary, as little as possible). 
This pre-requires a working institutional governance 
scheme and – as governance information is not regu-
larly implemented with the data – a large amount of 
curation.
Despite the broad availability of interoperability specifi-
cations, there is pervasive non-adherence to HL7 messag-
ing standards (by using inappropriate levels), incomplete 
LOINC mapping (e.g. for not yet categorized analyses), 
inconsistently reported results (e.g. due to historical data 
structures) and non-adoption of SNOMED CT standards 
when reporting electronic laboratory results. These barri-
ers must be overcome in order to efficiently deploy systems 
that utilize real-world data for secondary use. Ideally this 
is accomplished by source systems adopting and strictly 
adhering to specified standards. However, our experience 
shows that this is a cumbersome approach that depends 
on many, partly unforeseen instances including techni-
cal, legal and operational issues. Alternatively, complex 
systems can be used that compensate for sub-standard 
data by using robust techniques for mapping local codes 
to LOINC and multiple natural language processing (NLP) 
algorithms (cf. SPHN project “NLP-powered mapping 
of clinical reports onto SNOMED-CT concepts for tumor 
classification [NLPforTC]”7). Such systems also require 
periodic evaluation to ascertain accuracy. Today, it is 
evident that the accuracy of the source data is of utmost 
importance for the later use of this data in subsequent 
projects. However, it is at present not clear whom to charge 
with the efforts to cleanse databases that were improperly 
filled over the years.
The Insel clinical data warehouse 
(IDWH)
The first key principle of the Inselspital’s CDWH initiative 
is to establish a data management and analysis platform 
not only for research, but also for patient treatment and 
hospital operations to optimally use synergies of a com-
prehensive analytics platform. The second key principle 
consists of building a modular architecture that is highly 
open and flexible, can evolve over time and thus will be 
able to meet future requirements. The core of the CDWH 
consists of a data lake infrastructure to maintain the data 
extracted from the source systems. Data persistence in the 
data lake is two-fold: a relational database management 
system for structured data and the Apache Hadoop project 
(Hadoop) distributed file system for unstructured and 
high-volume data. As we have an in-hospital system, we 
can link the data with the patient identification number, 
and technological bridges allow to query from both the 
structured and the unstructured part of the data lake. 
Our system scales horizontally to integrate various data 
sources that not only differ in technology and formats, 
but could also originate from either internal or external 
systems, admitting that part of our hospital infrastructure 
has an “external” label as it belongs to the university as a 
separate entity and not to the hospital – a rather common 
setting in university medicine. The preferred way to inte-
grate a new source is to directly attach the source database 
to the ETL process and to integrate the raw source data 
one-to-one into the data lake (cf. Figure 1). As in our case, 
the LIMS is based on a large number of connected tables, a 
single, pre-generated “view” is mirrored on the data lake. 
Alternative ways consist in using existing export inter-
faces like HL7 or proprietary file formats. The direct access 
to the source system database facilitates data profiling, 
automatic identification of outliers and scaffolding the 
data catalogue for documenting the data, if such a reposi-
tory is available at all. Nevertheless, an appalling issue 
can be the data structure in the source systems, which is 
rarely optimized to be queried via a CDWH. Data quality 
issues are handled in cooperation with the source system 
team or flagged as poor quality in order to filter these 
parts of the data out subsequently. The approach should 
be recursive: cleaning the sources as well as possible, tag 
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problematic entries, elucidate the underlying problem 
and avoid re-occurrence within the sources. Especially 
in the LIMS, many auxiliary variables and quality control 
measurements are recorded, which are not relevant for 
a specific reported result. On the other hand, such data 
can be useful for “cockpit” applications or other monitor-
ing tools. The use cases then define the processing of raw 
data to subsequent layers of the data warehouse accord-
ing to “The Wisdom of Late Binding” postulated by Health 
Catalyst,15 keeping in mind that other, not readily bound 
data fields of the source data system might be relevant for 
other use cases. Late binding allows to quickly adapt to 
new studies or use cases and to deliver the relevant dataset 
into a use case specific data mart, which at the Inselspital 
is entitled “Data Atelier”. Data ateliers are – depending on 
the data governance – either identified, de-identified or 
fully anonymized. If the atelier owners need further adjust-
ment, processing or formatting of the data, the delivery 
scripts can easily be adapted. The data pipelines that can 
be built to transform raw data into use case specific data 
marts vary from simple ETL processes or SQL queries to 
complex statistical procedures and modeling approaches 
or NLP algorithms for text mining.
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